The University of Washington Alzheimer's Disease Research Center investigates the basic mechanisms causing the development of Alzheimer’s disease and related disorders. We also direct particular attention to biomarkers, experimental new treatments, and studies that search for genetic risk factors underlying Alzheimer's disease. Our main priorities are to find the causes of Alzheimer’s and to identify effective treatments and prevention strategies for this tragic disorder. The ultimate goal of our basic and clinical studies is to improve patient care and functioning, as well as to improve the quality of life for both patients and caregivers.
The UW ADRC creates a culture that helps researchers attain new knowledge about Alzheimer’s and related dementias and then helps them apply this knowledge to the development of innovative therapies. This goal is achieved by gathering a multidisciplinary group of basic and clinical investigators, including neurologists, psychiatrists, neuropsychologists, cell and molecular neurobiologists, neuropathologists, geneticists, biostatisticians, geriatricians, and others. These ADRC researchers work with fellows, volunteer research participants, community partners, and scientific collaborators locally, nationally, and internationally. Our investigators also partner with other Alzheimer’s centers across the country to evaluate promising new medications and other treatments for Alzheimer’s. Through these endeavors, the ADRC continues its education and training mission to develop the careers of new Alzheimer’s investigators and to enhance the knowledge of health care professionals and lay caregivers.